Advertisement
Screener

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price

2.3 / 5 stars · 38/82 Roast Me

ADAPTIMMUNE THERAPEUTICS PLC Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of GBP 0.42 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-27.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2019-02-27

  • ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2018 was 0.42 GBP.

GBP

Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month
2018-12-310.42 GBP
10-K · filed 2019-02-27

USD/shares

Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month
2017-12-31$0.19
10-K · filed 2018-03-15
2016-12-31$0.22
10-K · filed 2017-03-13

GBP/shares

Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month
2018-12-310.42 GBP/shares
10-K · filed 2019-02-27